SCHEMBL20199139

SCHEMBL20199139

CCSNCCNc1nonc1/C(=N/O)Nc1cccc(C(F)(F)F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.46
▸ LMNA P02545 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 4/20 0.38
▸ GAA P10253 1/20 0.38
▸ NPY1R P25929 1/20 0.38
▸ TP53 P04637 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ KDR P35968 3/20 0.37
▸ BRAF P15056 2/20 0.37
▸ MAPK14 Q16539 2/20 0.37
▸ TNNI3K Q59H18 2/20 0.37
▸ AURKB Q96GD4 1/20 0.37
▸ IKBKB O14920 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ CCR2 P41597 1/20 0.37
▸ CCR5 P51681 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199189 0.91 IDO1 (0.47) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL19881740 0.85 ALDH1A1 (0.46) IDO1LMNAALDH1A1MAPTTP53
SCHEMBL145200 0.85 IDO1 (0.51) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL30865861 0.85 IDO1 (0.51) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL145201 0.85 IDO1 (0.51) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL30448914 0.84 IDO1 (0.49) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL30449652 0.84 IDO1 (0.49) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL147069 0.84 IDO1 (0.49) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL147068 0.84 IDO1 (0.49) IDO1LMNAALDH1A1MAPTGAA
SCHEMBL20198881 0.84 IDO1 (0.46) IDO1LMNAALDH1A1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018095432-A1 SULFOXIMINE, SULFONIMIDAMIDE, SULFONDIIMINE AND DIIMIDOSULFONAMIDE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2, 3-DIOXYGENASE SHANGHAI FOCHON PHARMACEUTICAL CO., LTD. (CN) 2018-05-31 — — WO disclosed
Send feedback